Exact Therapeutics AS (EXTX) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.697x

Based on the latest financial reports, Exact Therapeutics AS (EXTX) has a cash flow conversion efficiency ratio of -0.697x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-80.55 Million ≈ $-8.48 Million USD) by net assets (Nkr115.55 Million ≈ $12.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EXTX market cap overview for the company's overall valuation and market capitalisation.

Exact Therapeutics AS - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Exact Therapeutics AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Exact Therapeutics AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Exact Therapeutics AS ranked by their cash flow conversion efficiency. See EXTX cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
PMPG Polskie Media S.A. WAR:PGM	-0.105x
Lenox Pasifik Investama Tbk PT JK:LPPS	0.000x
Gungnir Resources Inc V:GUG	-0.011x
Eng Kah Corporation Bhd KLSE:7149	-0.023x
Global IBO Group Ltd NASDAQ:GIBO	-0.001x
Bryah Resources Ltd AU:BYH	-0.063x
ROCCA SA ZY -05 F:82J	-0.008x
SOLAI Limited NYSE:SLAI	-0.355x

Annual Cash Flow Conversion Efficiency for Exact Therapeutics AS (2017–2024)

The table below shows the annual cash flow conversion efficiency of Exact Therapeutics AS from 2017 to 2024. View Exact Therapeutics AS (EXTX) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr115.55 Million ≈ $12.16 Million	Nkr-80.55 Million ≈ $-8.48 Million	-0.697x	+29.02%
2023-12-31	Nkr45.10 Million ≈ $4.75 Million	Nkr-44.30 Million ≈ $-4.66 Million	-0.982x	-88.90%
2022-12-31	Nkr65.11 Million ≈ $6.85 Million	Nkr-33.85 Million ≈ $-3.56 Million	-0.520x	+0.24%
2021-12-31	Nkr105.74 Million ≈ $11.13 Million	Nkr-55.11 Million ≈ $-5.80 Million	-0.521x	-220.16%
2020-12-31	Nkr159.65 Million ≈ $16.80 Million	Nkr-25.99 Million ≈ $-2.73 Million	-0.163x	+44.84%
2019-12-31	Nkr42.24 Million ≈ $4.44 Million	Nkr-12.46 Million ≈ $-1.31 Million	-0.295x	-35.10%
2018-12-31	Nkr57.06 Million ≈ $6.00 Million	Nkr-12.46 Million ≈ $-1.31 Million	-0.218x	+85.37%
2017-12-31	Nkr8.35 Million ≈ $878.27K	Nkr-12.46 Million ≈ $-1.31 Million	-1.493x	--

About Exact Therapeutics AS

OL:EXTX Norway Biotechnology

Market Cap

$5.26 Million

Nkr49.98 Million NOK

Market Cap Rank

#28572 Global

#257 in Norway

Share Price

Nkr0.79

Change (1 day)

+1.28%

52-Week Range

Nkr0.61 - Nkr2.70

All Time High

Nkr40.90